Lastly, compared to other abroad cohorts, CASQ2 mutation is more common in Chinese pediatric CPVT patients, and these children presented with a relatively lower trend in onset age, higher rate of positive family history, and better prognosis in comparison with those with RYR2 mutation. This evidence concerns the gene CASQ2 and catecholaminergic polymorphic ventricular tachycardia.